We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

198 hedge funds and large institutions have $1.22B invested in Immunogen Inc in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 55

11% more capital invested

Capital invested by funds: $1.1B → $1.22B (+$119M)

1% more call options, than puts

Call options by funds: $8.07M | Put options by funds: $8.01M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 204 → 198 (-6)

13% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 32

Holders
198
Holders Change
-6
Holders Change %
-2.94%
% of All Funds
4.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
74
Reduced
55
Closed
32
Calls
$8.07M
Puts
$8.01M
Net Calls
+$54K
Net Calls Change
+$18.7M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$41.4M
2
RG
Redmile Group
California
+$27.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.3M
4
BlackRock
BlackRock
New York
+$21.9M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$21.7M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$17.6M
2
Millennium Management
Millennium Management
New York
-$14.5M
3
Franklin Resources
Franklin Resources
California
-$9.86M
4
Invesco
Invesco
Georgia
-$7.69M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$7.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
26
Pinnacle Associates
New York
$10.7M -$1.8M -170,570 -13%
Capital World Investors
27
Capital World Investors
California
$9.24M +$10M +950,000 New
PAM
28
Panagora Asset Management
Massachusetts
$8.79M +$523K +49,607 +6%
Charles Schwab
29
Charles Schwab
California
$7.45M +$2.48M +234,880 +44%
Allianz Asset Management
30
Allianz Asset Management
Germany
$7.4M +$4.08M +386,834 +103%
CS
31
Candriam SCA
Luxembourg
$6.75M +$1.05M +100,000 +17%
RJA
32
Raymond James & Associates
Florida
$6.31M +$247K +23,459 +4%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$5.31M -$470K -44,602 -8%
Norges Bank
34
Norges Bank
Norway
$5.2M +$2.11M +200,000 +60%
CEP
35
Chicago Equity Partners
Illinois
$5.12M +$241K +22,895 +5%
First Trust Advisors
36
First Trust Advisors
Illinois
$3.6M +$3.9M +369,528 New
Deutsche Bank
37
Deutsche Bank
Germany
$3.36M -$6.52M -618,288 -64%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$3.09M -$3.87M -366,818 -54%
MIM
39
Monashee Investment Management
Massachusetts
$2.68M – – –
Millennium Management
40
Millennium Management
New York
$2.5M -$14.5M -1,373,778 -84%
Swiss National Bank
41
Swiss National Bank
Switzerland
$2.47M +$373K +35,400 +16%
Invesco
42
Invesco
Georgia
$2.41M -$7.69M -729,938 -75%
Wellington Management Group
43
Wellington Management Group
Massachusetts
$2.41M +$472K +44,758 +22%
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$2.2M +$448K +42,530 +23%
GC
45
Guggenheim Capital
Illinois
$2.18M +$190K +18,018 +9%
AllianceBernstein
46
AllianceBernstein
Tennessee
$2.1M +$1.01M +95,353 +79%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$1.99M +$2.16M +204,474 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.91M +$464K +44,015 +29%
AA
49
ALPS Advisors
Colorado
$1.88M +$165K +15,693 +9%
CS
50
Credit Suisse
Switzerland
$1.85M +$597K +56,675 +43%
1
2
3 4 5

IMGN Hedge Fund Activity: Q2 2018 in Review

198 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2018, worth a combined $1.22B — up 11% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of IMGN and 28 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 74 added.

The largest buyer was Capital Research Global Investors, adding an estimated $41.4M. The largest seller was PointState Capital, exiting entirely with an estimated $17.6M sold.

  • 198 institutional investors held Immunogen Inc (IMGN) as of Q2 2018, down from 204 in Q1 2018.
  • Funds reported $1.22B of Immunogen Inc stock for Q2 2018, up 11% quarter-over-quarter.
  • 28 funds opened new Immunogen Inc positions in Q2 2018 and 32 closed out, a net change of -4 holders.
  • The largest Immunogen Inc buyer in Q2 2018 was Capital Research Global Investors, an estimated $41.4M added.
  • The largest Immunogen Inc seller in Q2 2018 was PointState Capital, an estimated $17.6M sold.

Based on aggregated 13F filings for Q2 2018.